Laura Polastro

Department : Medical oncology , Day hospital

laura.polastro [at] hubruxelles.be

Publications

Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells.

Authors : Gómez-Aleza C, Nguyen B, Yoldi G, Ciscar M, Barranco A, Hernández-Jiménez E, Maetens M, Salgado R, Zafeiroglou M, Pellegrini P, Venet D, Garaud S, Trinidad EM, Benítez S, Vuylsteke P, Polastro L, Wildiers H, Simon P, Lindeman G, Larsimont D, Van den Eynden G, Velghe C, Rothé F, Willard-Gallo K, Michiels S, Muñoz P, Walzer T, Planelles L, Penninger J, Azim HA Jr, Loi S, Piccart-Gebhart M, Sotiriou C, González-Suárez E
Year : 2020
Journal : Nat Commun

Immunotherapy in gynecological cancers: where are we?

Authors : Polastro L, Closset C, Kerger J
Year : 2020
Journal : Curr Opin Oncol

MOMENTUM: A Phase I Trial Investigating 2 Schedules of Capecitabine With Aflibercept in Patients With Gastrointestinal and Breast Cancer.

Authors : Camera S, Deleporte A, Bregni G, Trevisi E, Pretta A, Telli TA, Polastro L, Gombos A, Kayumba A, Ameye L, Piccart-Gebhart M, Awada A, Sclafani F, Hendlisz A
Year : 2020
Journal : Clin Colorectal Cancer

A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.

Authors : Liberale G, Pop FC, Polastro L, Kerger J, Moreau M, Chintinne M, Larsimont D, Nogaret JM, Veys I
Year : 2020
Journal : J Visc Surg

Pseudoadjuvant chemotherapy in resectable metastatic colorectal cancer.

Authors : Polastro L, El Hachem G, Hendlisz A
Year : 2018
Journal : Curr Opin Oncol

More publications »

Laura Polastro

Languages

Contact